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In a recent survey of 40 consecutive cases ofprimary malignant lymphoma of
the small and large intestine seen in the Vincent Square Laboratories of West-
minster Medical School and the Research Department of St. Mark's Hospital, London, there were 5 carcinomas, an incidence of 12-5 per cent. Some data con-
cerning the 40 cases of primary malignant lymphoma of the intestinal tract are
given in Table 1, and brief details of the 5 carcinomas are given in Table II.
TABLE I.-Incidence of Carcinoma in Patient8 with Primary Malignant Lymphomas ofthe Small and Large Intestine
Number of Percentage of
Number of patients with patients with
Cell type patients carcinoma carcinoma
Hodgkin's disease 5 0
Reticulum cell sarcoma 14 1 12- 5 Giant follicle lymphoma I 0
Lymphosarcoma 20 4
Total 40 5
Detailed accounts of four of the five carcinomas have been published elsewhere
(Cornes, 1960, 1961). In a further study of 100 cases ofbenign lymphoma of the
rectum there were seven carcinomas, an incidence of 7 per cent (Cornes, Wallace
and Morson, 196.1). The large number of cases in these two series reflects the
specialised work ofthe St. Mark's and Gordon Hospitals in the surgical treatment
of intestinal disorders. Since more than half the patients in these two series are
still alive the incidence of carcinoma may eventually prove to be higher than that
stated. We were therefore interested to compare these findings with the incidence
of carcinoma in patients dying from leukaemia or from generalised malignant tumours oflymphoid tissue.
Slaughter (1944) and Warren and Ehrenreich (1944), in their studies ofmultiple malignancy, concluded that multiple primary cancers arose more frequently than
would be expected by chance alone. However, Morrison, Feldman and Samwick
(1944) found only two instances of carcinoma in a series of 600 patients suffering from leukaemia, and Mider, Schilling, Donovan and Rendall (1952) found only 16 primary cancers in 519 patients with leukaemia or malignant lymphoma. Videbaek (1947) in astudy of 209 patients with leukaemia, 4041 oftheirrelatives,
and 3641 controls, found a higher incidence of cancer in the leukaemia familiesCARCINOMA IN LEUKAEMIA AND OTHER MALIGNANT DISORDERS 201
than in the control population, and Beresford (1952) found 19 cases of carcinoma
in 106 patients with chronic lymphatic leukaemia. Moertel and Hagedorn (1957)
reviewing 194 cases of leukaemia and malignant lymphoma with co-existent
primary malignant lesions reported in the literature, and 120 similar cases seen
at the Mayo Clinic, concluded that the incidence of another primary malignant
lesioninpatientswithleukaemia ormalignantlymphoma wasprobablycomparable
to, and perhaps exceeded, that in any segment of the general population of similar
age. Weitzel (1958) in a survey of 3398 patients dying from carcinoma, and 365
patients dying from lymphoma or leukaemia, who came to autopsy at theMallory
Institute of Pathology in Boston, found that the incidence of multiple primary
carcinomas was 4-2 per cent and the incidence of carcinoma co-existent with lym-
phoma and leukaemia was 8-0 per cent. A striking feature of this series was
the finding of II carcinomas with 57 cases ofmalignant disorders ofplasma cells,
an incidence of 19-3 per cent.
Because of the general lack of agreement between the series reported in the
literature we decided to find out the incidence of carcinoma inpatientsdying from
leukaemia, malignant disorders of plasma cells, and malginant lymphoma, who
came to autopsy at the Westminster and the Postgraduate Medical Schools of
London University.
MATERIALS AND METHODS
Thisstudy was based on 9383 autopsiesperformed at thePostgraduate Medical
School, London, between April 1935 and October 1960, and on 5561 autopsies
performed at the Westminster Medical School between 1938 and October 1960.
Theautopsies wereperformed to determine the causes ofdeath, to assess the nature
and extent of the principal diseases, and to detect any associated disorders.
Amongst these 14'944 autopsies there were 585 cases of leukaemia, multiple
myeloma, andmalignantlymphoma. The clinical records andpost-mortemreports
of the 585 cases were studied to find out the number ofpatients with carcinoma.
Thediagnosis ofleukaemia was based on astudy ofperipheral blood films andbone
marrow biopsies which were taken in every case, and as far as possible we have
tried to eliminate all leukaemoid reactions. For the sake of convenience the sub-
acute and acute forms of leukaemia have been considered together, and the
monocytic leukaemia-s include both theNaegeli and theSchilling types. The diag-
nosis ofmultiple myeloma andmalignantlymphoma was based on the histological
TABLE II.-Details of 5 Carcinomasfound in Patient-s with Primary Malignant
Lymphoma of the Intestinal Tract
Carcinoma
Patient Type of Treatment of Relation of
Meta- malignant malignant carcinoma to
Age Sex Site Tvpe stases lymphoma lymphoma lymphoma
57 M. Rectuin Adenocareinoma 0 Lymphosarcoma Resection and Simultaneous.
radiotherapy
52 Colon .31 0 Ditto Followed-
I year.
52 Colon and Adenocareinoma + Reticulum cefl Followed-
rectum (multiple) sarcoma 20 months.
66 Prostate Adenocareinoma 0 Lymphosarcoma None Simultaneous.
48 Bronchus Anaplastic + Lymphosarcoma Resection and Followed-
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study ofbiopsies taken in life, and on the findings at autopsy. The classification
of the malignant lymphomas used in this study corresponds with that given by
Harrison (1960). Sections of all the carcinomas were available for study, and the
clinical diagnoses were confirmed histologically in every case. Apart from leu-
kaemia, multiple myeloma and malignant lymphoma, no other type of sarcoma
was found in this series.
RESULTS
The incidence of carcinoma in patients dying from leukaemia, malignant
disordersofplasmacells, andmalignantlymphoma, isshowninTableIII. Amongst
265 cases of leukaemia three were 9 carcinomas, an incidence of 3-4 per cent.
Amongst 43 cases ofmalignant disorders ofplasma cells there were 2 carcinomas,
TABLEIII.-Incidence of Carcinoma in PatienMDyingfrom Leukaemia,
Malignant Di8orders ofPla8ma CeIM, and Malignant Lymphoma
Number of Percentage of
Number of patients with patients with
Cell type patients carcinoma carcinoma
Acute myeloid leukaemia 54 2
Acute lymphatic leukaemia 48 0 2- 7 Acute monocytic leukaemia 32 I
Stem cell leukaemia 13 I
Chronic myeloid leukaemia 56 1
Chronic lymphatic leukaemia 58 3 3-4
Chronic monocytic leukaemia I 0
Plasma cefl leukaemia 2 1 4-6 Multiple myeloma 41 I
Hodgkin's disease 132 I
Reticulum cell sarcoma 91 4 2-i Giant follicle lymphoma 8 0
Lymphosarcoma 49 1
Total 585 16 2
- 7
an incidence. of 4-6 per cent; and amongst 280 cases of malignant lymphoma there were 6 carcinomas, an incidence of 2-1 per cent. The total number of carci-
nomas found in the 585 cases was 16, giving an overall incidence of 2-7 per cent.
Brief details of the 16 cases with carcinoma are given in Table IV, the age given being that at the time of diagnosis of the leukaemia, malignant lymphoma
or multiple myeloma. In 8 cases the carcinomas developed before the onset of
leukaemia ormalignantlymphoma. In 3 casesthe carcinomasapparentlydeveloped simultaneously with the onset ofmalignant disorders ofplasma cells ormalignant lymphoma. In the remaining 5 cases the carcinomas developed after the onset of
leukaemia or malignant lymphoma. At autopsy carcinomatous metastases were
found in only 5 cases.
DISCUSSION
The autopsy services of the Westminster Medical School and the Postgraduate Medical School. serve busy general hospitals caring for every type of patient. Both centres are distinguished for their treatment ofmalignant disease, and anvCARCINOMA IN LEUKAEMIA AND OTHER MALIGNANT DISORDERS 203
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bias in the selection ofpatients would tend to favour ahigh incidence ofmalignant
conditions in the patients coming to autopsy. In spite of this the incidence
of carcinoma in the patients dying from leukaemia, multiple myeloma, and
malignant lymphoma is low. The high incidence of carcinoma in patients dying
from malignant disorders ofplasma cells noted by Weitzel (1958) was not found
in this series, and no special association was found between the development of
carcinoma and any other particular type of leukaemia or malignant lymphoma.
Of the 280 patients with a malignant lymphoma, only one had a possible
origin in the gastro-intestinal tract. The low incidence of carcinoma in this
series (2-1 per cent) compared with the much higher incidence of carcinoma
(12-5 per cent) in the series of 40 cases of primary malignant lymphoma of the
small and large intestines (Cornes, 1961) remains an interesting observation.
These series are too small for any definite conclusions to be made, and further
studies are required to determine if there is any significance in the association
between carcinoma and lymphoma of the intestinal tract. From the clinical
point of view, however, it is important to recognise that carcinomas can develop
in these cases, and one should not be too ready in assuming that a second tumour
is necessarily a recurrence or a metastasis from the original primary lymphoma.
SUMMARY
1. A survey was made of 14,944post-mortemreports, and 585 cases ofpatient's
dying from leukaemia, malignant disorders of plasma cells, and malignant
lymphoma, were selected for study.
2. Sixteen carcinomas were foundinthis series of585 cases, an overall incidence
of 2-7 per cent. No significant association was found between the development
of carcinoma and the different types of leukaemia or malignant lymphoma, and
in particular there was no special association between the development of
carcinoma and malignant disorders ofplasma cells.
3. The low incidence of carcinoma (2-1 per cent) in patients dying from
malignant lymphoma is contrasted with a high incidence of carcinoma (12-5
per cent) in patients with primary malignant lymphoma of the small or large
intestine. Further studies from other large centres are required to assess the
significance of this association.
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